Methods and marker combinations for screening for predisposition to lung cancer

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9347945
APP PUB NO 20080160546A1
SERIAL NO

11771727

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to rapid, sensitive methods for determining whether a subject is at risk of developing lung cancer or has lung cancer based on certain combinations or biomarkers or biomarkers and biometric parameters.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ABBOTT MOLECULAR INC1300 E TOUHY AVENUE DES PLAINES IL 60018

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Colpitts, Tracey Round Lake, US 8 63
Frost, Stephen Gurnee, US 13 79
Ramirez, Javier Gurnee, US 10 87
Russell, Eric L Gurnee, US 6 67
Russell, John C Kenosha, US 86 612
Singh, Bhawani Wilmette, US 9 90

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 24, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00